Logo image of SNW.DE

SANOFI (SNW.DE) Stock Price, Quote, News and Overview

FRA:SNW - Deutsche Boerse Ag - FR0000120578 - Common Stock - Currency: EUR

93.43  -0.16 (-0.17%)

SNW.DE Quote, Performance and Key Statistics

SANOFI

FRA:SNW (5/22/2025, 7:00:00 PM)

93.43

-0.16 (-0.17%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High110.82
52 Week Low86
Market Cap228.72B
Shares2.45B
Float2.19B
Yearly Dividend3.79
Dividend Yield4.36%
PE13.88
Fwd PE10.24
Earnings (Next)07-31 2025-07-31/bmo
IPO07-01 2002-07-01


SNW.DE short term performance overview.The bars show the price performance of SNW.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10

SNW.DE long term performance overview.The bars show the price performance of SNW.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 2 -2 4 -4 -6

The current stock price of SNW.DE is 93.43 EUR. In the past month the price increased by 0.03%. In the past year, price increased by 4.62%.

SANOFI / SNW Daily stock chart

SNW.DE Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1LLY.MI ELI LILLY & CO 52.04 600.36B
LLY.DE ELI LILLY & CO 51.77 597.23B
ZEG.DE ASTRAZENECA PLC 18.95 383.67B
1JNJ.MI JOHNSON & JOHNSON 15.21 325.25B
JNJ.DE JOHNSON & JOHNSON 15.17 324.46B
NOV.DE NOVO NORDISK A/S-B 19.35 264.57B
RHO.DE ROCHE HOLDING AG-BR 14.64 238.41B
1SAN.MI SANOFI 13.96 230.07B
SAN.PA SANOFI 13.71 225.83B
NOT.DE NOVARTIS AG-REG 13.57 196.52B
6MK.DE MERCK & CO. INC. 9.9 171.62B
1MRKX.MI MERCK & CO. INC. 9.88 171.37B

About SNW.DE

Company Profile

SNW logo image Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 84,587 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Company Info

SANOFI

46 Avenue de la Grande Armee

Paris ILE-DE-FRANCE FR

Employees: 82878

SNW Company Website

SNW Investor Relations

Phone: 33153774000

SANOFI / SNW.DE FAQ

What is the stock price of SANOFI today?

The current stock price of SNW.DE is 93.43 EUR. The price decreased by -0.17% in the last trading session.


What is the ticker symbol for SANOFI stock?

The exchange symbol of SANOFI is SNW and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is SNW.DE stock listed?

SNW.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for SANOFI stock?

29 analysts have analysed SNW.DE and the average price target is 119.33 EUR. This implies a price increase of 27.73% is expected in the next year compared to the current price of 93.43. Check the SANOFI stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SANOFI worth?

SANOFI (SNW.DE) has a market capitalization of 228.72B EUR. This makes SNW.DE a Mega Cap stock.


How many employees does SANOFI have?

SANOFI (SNW.DE) currently has 82878 employees.


What are the support and resistance levels for SANOFI (SNW.DE) stock?

SANOFI (SNW.DE) has a support level at 92.97 and a resistance level at 95.9. Check the full technical report for a detailed analysis of SNW.DE support and resistance levels.


Is SANOFI (SNW.DE) expected to grow?

The Revenue of SANOFI (SNW.DE) is expected to grow by 1.53% in the next year. Check the estimates tab for more information on the SNW.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SANOFI (SNW.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SANOFI (SNW.DE) stock pay dividends?

SANOFI (SNW.DE) has a dividend yield of 4.36%. The yearly dividend amount is currently 3.79. Check the full fundamental report for a detailed analysis of SNW.DE dividend history, reliability and sustainability.


When does SANOFI (SNW.DE) report earnings?

SANOFI (SNW.DE) will report earnings on 2025-07-31, before the market open.


What is the Price/Earnings (PE) ratio of SANOFI (SNW.DE)?

The PE ratio for SANOFI (SNW.DE) is 13.88. This is based on the reported non-GAAP earnings per share of 6.73 and the current share price of 93.43 EUR. Check the full fundamental report for a full analysis of the valuation metrics for SNW.DE.


SNW.DE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to SNW.DE. When comparing the yearly performance of all stocks, SNW.DE is a bad performer in the overall market: 66.99% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SNW.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to SNW.DE. While SNW.DE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SNW.DE Financial Highlights

Over the last trailing twelve months SNW.DE reported a non-GAAP Earnings per Share(EPS) of 6.73. The EPS decreased by -12.99% compared to the year before.


Industry RankSector Rank
PM (TTM) 12.97%
ROA 9%
ROE 15.37%
Debt/Equity 0.17
Chartmill High Growth Momentum
EPS Q2Q%-53.61%
Sales Q2Q%-12.62%
EPS 1Y (TTM)-12.99%
Revenue 1Y (TTM)30.3%

SNW.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to SNW.DE. The Buy consensus is the average rating of analysts ratings from 29 analysts.

For the next year, analysts expect an EPS growth of 8.37% and a revenue growth 1.53% for SNW.DE


Ownership
Inst Owners39.32%
Ins Owners0.01%
Short Float %N/A
Short RatioN/A
Analysts
Analysts80
Price Target119.33 (27.72%)
EPS Next Y8.37%
Revenue Next Year1.53%